These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 34623184)

  • 1. Cortical bone stem cell-derived exosomes' therapeutic effect on myocardial ischemia-reperfusion and cardiac remodeling.
    Schena GJ; Murray EK; Hildebrand AN; Headrick AL; Yang Y; Koch KA; Kubo H; Eaton D; Johnson J; Berretta R; Mohsin S; Kishore R; McKinsey TA; Elrod JW; Houser SR
    Am J Physiol Heart Circ Physiol; 2021 Dec; 321(6):H1014-H1029. PubMed ID: 34623184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cortical Bone Stem Cell Therapy Preserves Cardiac Structure and Function After Myocardial Infarction.
    Sharp TE; Schena GJ; Hobby AR; Starosta T; Berretta RM; Wallner M; Borghetti G; Gross P; Yu D; Johnson J; Feldsott E; Trappanese DM; Toib A; Rabinowitz JE; George JC; Kubo H; Mohsin S; Houser SR
    Circ Res; 2017 Nov; 121(11):1263-1278. PubMed ID: 28912121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cortical bone stem cells modify cardiac inflammation after myocardial infarction by inducing a novel macrophage phenotype.
    Hobby ARH; Berretta RM; Eaton DM; Kubo H; Feldsott E; Yang Y; Headrick AL; Koch KA; Rubino M; Kurian J; Khan M; Tan Y; Mohsin S; Gallucci S; McKinsey TA; Houser SR
    Am J Physiol Heart Circ Physiol; 2021 Oct; 321(4):H684-H701. PubMed ID: 34415185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cortical bone-derived stem cell therapy reduces apoptosis after myocardial infarction.
    Hobby ARH; Sharp TE; Berretta RM; Borghetti G; Feldsott E; Mohsin S; Houser SR
    Am J Physiol Heart Circ Physiol; 2019 Oct; 317(4):H820-H829. PubMed ID: 31441690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic basis of modulation of postischemic fibrosis by MSC exosomes.
    Kore RA; Wang X; Henson JC; Ding Z; Jamshidi-Parsian A; Mehta JL
    Am J Physiol Regul Integr Comp Physiol; 2021 Nov; 321(5):R639-R654. PubMed ID: 34431382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal stromal cell-derived exosomes attenuate myocardial ischaemia-reperfusion injury through miR-182-regulated macrophage polarization.
    Zhao J; Li X; Hu J; Chen F; Qiao S; Sun X; Gao L; Xie J; Xu B
    Cardiovasc Res; 2019 Jun; 115(7):1205-1216. PubMed ID: 30753344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury.
    Arslan F; Lai RC; Smeets MB; Akeroyd L; Choo A; Aguor EN; Timmers L; van Rijen HV; Doevendans PA; Pasterkamp G; Lim SK; de Kleijn DP
    Stem Cell Res; 2013 May; 10(3):301-12. PubMed ID: 23399448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardioprotection by cardiac progenitor cell-secreted exosomes: role of pregnancy-associated plasma protein-A.
    Barile L; Cervio E; Lionetti V; Milano G; Ciullo A; Biemmi V; Bolis S; Altomare C; Matteucci M; Di Silvestre D; Brambilla F; Fertig TE; Torre T; Demertzis S; Mauri P; Moccetti T; Vassalli G
    Cardiovasc Res; 2018 Jun; 114(7):992-1005. PubMed ID: 29518183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amphiregulin enhances cardiac fibrosis and aggravates cardiac dysfunction in mice with experimental myocardial infarction partly through activating EGFR-dependent pathway.
    Liu L; Jin X; Hu CF; Zhang YP; Zhou Z; Li R; Shen CX
    Basic Res Cardiol; 2018 Jan; 113(2):12. PubMed ID: 29349588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mir-30d Regulates Cardiac Remodeling by Intracellular and Paracrine Signaling.
    Li J; Salvador AM; Li G; Valkov N; Ziegler O; Yeri A; Yang Xiao C; Meechoovet B; Alsop E; Rodosthenous RS; Kundu P; Huan T; Levy D; Tigges J; Pico AR; Ghiran I; Silverman MG; Meng X; Kitchen R; Xu J; Van Keuren-Jensen K; Shah R; Xiao J; Das S
    Circ Res; 2021 Jan; 128(1):e1-e23. PubMed ID: 33092465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trop2 Guarantees Cardioprotective Effects of Cortical Bone-Derived Stem Cells on Myocardial Ischemia/Reperfusion Injury.
    Li T; Su Y; Yu X; Mouniir DSA; Masau JF; Wei X; Yang J
    Cell Transplant; 2018 Aug; 27(8):1256-1268. PubMed ID: 30008230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial fibroblast growth factor receptor signaling is required for vascular remodeling following cardiac ischemia-reperfusion injury.
    House SL; Castro AM; Lupu TS; Weinheimer C; Smith C; Kovacs A; Ornitz DM
    Am J Physiol Heart Circ Physiol; 2016 Mar; 310(5):H559-71. PubMed ID: 26747503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transplantation of Cardiac Mesenchymal Stem Cell-Derived Exosomes Promotes Repair in Ischemic Myocardium.
    Ju C; Shen Y; Ma G; Liu Y; Cai J; Kim IM; Weintraub NL; Liu N; Tang Y
    J Cardiovasc Transl Res; 2018 Oct; 11(5):420-428. PubMed ID: 30232729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. M2b Macrophages Regulate Cardiac Fibroblast Activation and Alleviate Cardiac Fibrosis After Reperfusion Injury.
    Yue Y; Huang S; Wang L; Wu Z; Liang M; Li H; Lv L; Li W; Wu Z
    Circ J; 2020 Mar; 84(4):626-635. PubMed ID: 32161201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac fibroblasts secrete exosome microRNA to suppress cardiomyocyte pyroptosis in myocardial ischemia/reperfusion injury.
    Liu N; Xie L; Xiao P; Chen X; Kong W; Lou Q; Chen F; Lu X
    Mol Cell Biochem; 2022 Apr; 477(4):1249-1260. PubMed ID: 35119583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast Primary Cilia Are Required for Cardiac Fibrosis.
    Villalobos E; Criollo A; Schiattarella GG; Altamirano F; French KM; May HI; Jiang N; Nguyen NUN; Romero D; Roa JC; García L; Diaz-Araya G; Morselli E; Ferdous A; Conway SJ; Sadek HA; Gillette TG; Lavandero S; Hill JA
    Circulation; 2019 May; 139(20):2342-2357. PubMed ID: 30818997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone Marrow Mesenchymal Stem Cell-Derived Exosomal miRNA-29c Decreases Cardiac Ischemia/Reperfusion Injury Through Inhibition of Excessive Autophagy via the PTEN/Akt/mTOR Signaling Pathway.
    Li T; Gu J; Yang O; Wang J; Wang Y; Kong J
    Circ J; 2020 Jul; 84(8):1304-1311. PubMed ID: 32581152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic Effects of Ischemic-Preconditioned Exosomes in Cardiovascular Diseases.
    Ding S; Fan Z; Lin C; Dai Q; Zhou J; Huang H; Xu Y; Zhong C
    Adv Exp Med Biol; 2017; 998():271-281. PubMed ID: 28936746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-183-5p overexpression in bone mesenchymal stem cell-derived exosomes protects against myocardial ischemia/reperfusion injury by targeting FOXO1.
    Mao S; Zhao J; Zhang ZJ; Zhao Q
    Immunobiology; 2022 May; 227(3):152204. PubMed ID: 35314383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leonurine Attenuates Myocardial Fibrosis Through Upregulation of miR-29a-3p in Mice Post-myocardial Infarction.
    Wang R; Peng L; Lv D; Shang F; Yan J; Li G; Li D; Ouyang J; Yang J
    J Cardiovasc Pharmacol; 2021 Feb; 77(2):189-199. PubMed ID: 33235025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.